David Cole to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications David Cole has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.016
-
A phase II study of active immunotherapy with PANVAC or autologous, cultured dendritic cells infected with PANVAC after complete resection of hepatic metastases of colorectal carcinoma. Clin Colorectal Cancer. 2006 Jan; 5(5):368-71.
Score: 0.016